3 Tanking Marijuana Stocks That Still Aren’t Worth Buying

After tanking for months, CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) may have even further to fall

| More on:
Man considering whether to sell or buy

Image source: Getty Images.

Marijuana stocks spent the summer of 2019 falling into the abyss. Now, some are saying they’re ready for a comeback. In August, Canopy Growth Corp ex-CEO Bruce Linton went on the record as saying he was scooping up shares in his former company’s “sale.”

More recently, Fool contributor Joey Frenette wrote that Canopy had hit a support level and had become a possible buy. Indeed, Canopy and other weed stocks have been on the rise over the past week, perhaps vindicating the bulls’ thesis.

Nevertheless, there are other weed stocks that you still shouldn’t touch with a ten-foot pole. The following are just three of them.


Tilray Inc (NASDAQ:TLRY) is a former darling of the marijuana industry. After its IPO, it rose 755% in just under two months, making it the single biggest riser in summer 2018’s cannabis mania. More recently, however, the stock has fallen out of favour.

Thanks to the unbelievably high valuation it reached in 2018, TLRY was due for a correction. And “correct” it has, having falling 78% since its peak 2018 price. However, the stock still trades at a whopping 27 times sales despite having lost $35 million in its most recent quarter.


CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) is a stock that needs no introduction. After it was discovered growing pot in unlicensed rooms this past summer, it became the black sheep of the cannabis family.

As a result of its unlicensed activities, CannTrust has had holds placed on thousands of kilograms worth of its product by Health Canada.

The holds are large enough to prevent the company from earning any money this quarter, and its sales growth will likely stall when it next releases earnings. However, what happened in this most recent quarter isn’t even the worst of it.

The fact that CannTrust has been caught growing pot in unlicensed rooms not once, but twice, means that it will have extreme regulatory scrutiny on it going forward, which may force high compliance and legal costs on it for the foreseeable future.

Emerald Health Therapeutics

Emerald Health Therapeutics (TSXV:EMH) is a small-cap marijuana stock that produces a variety of CBD oil and dried cannabis products. Its focus on CBD oil is somewhat encouraging, as that product category tends to have higher margins than regular dried cannabis.

However, the stock has spent much of 2019 tanking, having fallen 60% from its peak price this year. The culprit, as with most marijuana stocks, seems to have been big losses: from 2015 to 2018, the company lost money each year.

Although the loss has been getting smaller over time, the company is still struggling to turn a profit on its cannabis operations.

On the other hand, the fact that the company’s Q2 loss of $450,000 was down from a $5 million loss a year before is very encouraging: that’s a big bite taken out of losses, and could be an indication that the company will become profitable soon.

For now, though, this stock remains one to pass on until future quarterly reports paint a better picture.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Canopy Growth Stock Worth Buying?

Canopy Growth stock (TSX:WEED) made a big move to consolidate its shares, but will this help the company move forward?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »